---
title: "NKGen Biotech, Inc. (NKGN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NKGN.US.md"
symbol: "NKGN.US"
name: "NKGen Biotech, Inc."
industry: "Biotechnology"
---

# NKGen Biotech, Inc. (NKGN.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [nkgenbiotech.com](https://nkgenbiotech.com) |

## Company Profile

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.33 | 122/604 | - | - | - |
| PB | -0.16 | 463/604 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/NKGN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NKGN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NKGN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.